Back
Johnson & Johnson (JNJ)
PharmaceuticalsJNJ · NEW YORK STOCK EXCHANGE, INC. · USD
New to investing? How to read this page →$256.93
−0.82%Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for education and research only — not financial advice.
Key metrics
EPS
$11.03
ROE
26.4%
Gross margin
68.0%
Debt/Equity
0.68x
Revenue growth
9.9%
Johnson & Johnson — company intelligence
Earnings surprises
Q1 2026$2.70 vs $2.69 est+0.3%
Q4 2025$2.46 vs $2.46 est-0.1%
Q3 2025$2.80 vs $2.78 est+0.5%
Q2 2025$2.77 vs $2.71 est+2.3%
Analyst consensus · 31 analysts
21 Buy10 Hold0 Sell
Updated Jul 7, 2026
Insider activity · 90 days
14 buys1 sellnet +1,535 shares
Wengel Kathryn Eother 10,000 · Jun 11, 2026
HEWSON MARILLYN ABuy 215 · Jun 9, 2026
Pinto Daniel EBuy 134 · Jun 9, 2026
Recent SEC filings
4 — Insider transaction reportJun 12, 2026
4 — Insider transaction reportJun 11, 2026
4 — Insider transaction reportJun 11, 2026
Latest news
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
About Johnson & Johnson
Weekly undervalued picks (like JNJ)
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.